Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription Articles published in Acta Haematol Retrieve available abstracts of 42 articles: HTML format Text format

Single Articles

August 2018
1. ABOU DALLE I, Cortes JE, Pinnamaneni P, Lamothe B, et al
   A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
   Acta Haematol. 2018;140:30-39.
   PubMed     Text format     Abstract available
   
   
   June 2018
2. PARK HS, Kim DY, Choi EJ, Lee JH, et al
   Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
   Acta Haematol. 2018;139:220-227.
   PubMed     Text format     Abstract available
   
   
   March 2018
3. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
   Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
   Acta Haematol. 2018;139:171-175.
   PubMed     Text format    
   
   
   February 2018
4. SONG X, Peng Y, Wang X, Chen Y, et al
   Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
   Acta Haematol. 2018;139:115-127.
   PubMed     Text format     Abstract available
   
   
   
5. BRUNNER AM
   No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
   Acta Haematol. 2018;139:128-130.
   PubMed     Text format    
   
   
   
6. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
   Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
   Acta Haematol. 2018;139:132-139.
   PubMed     Text format     Abstract available
   
   
   
7. TANG X, Zhou J, Zhang J, Zhou LY, et al
   Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
   Acta Haematol. 2018;139:89-95.
   PubMed     Text format     Abstract available
   
   
   January 2018
8. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
   Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
   Acta Haematol. 2018;139:58-59.
   PubMed     Text format    
   
   
   September 2017
9. LEADER A, Raanani P
   Switching-On Adherence in Chronic Myeloid Leukemia.
   Acta Haematol. 2017;138:138-139.
   PubMed     Text format    
   
   
   
10. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.
    PubMed     Text format    
    
    
    
11. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed     Text format    
    
    
    July 2017
12. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available
    
    
    
13. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available
    
    
    
14. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    
    
    
    June 2017
15. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Text format     Abstract available
    
    
    May 2017
16. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed     Text format    
    
    
    April 2017
17. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Text format     Abstract available
    
    
    
18. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed     Text format    
    
    
    
19. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available
    
    
    January 2017
20. QUINTELA A, Sujobert P, Callet-Bauchu E, Salles G, et al
    Ibrutinib-Induced Lymphocytosis: Cytological Features.
    Acta Haematol. 2017;137:55-57.
    PubMed     Text format    
    
    
    
21. LONGU F, Fozza C, Dessi L, Longinotti M, et al
    Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Acta Haematol. 2017;137:15-16.
    PubMed     Text format    
    
    
    
22. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Text format     Abstract available
    
    
    
23. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Text format     Abstract available
    
    
    
24. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Text format     Abstract available
    
    
    November 2016
25. SHENG G, Zeng Z, Pan J, Wang Q, et al
    t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2016;137:40-43.
    PubMed     Text format    
    
    
    October 2016
26. MORI N, Ohwashi-Miyazaki M, Okada M, Yoshinaga K, et al
    Translocation (9;12)(q34.1;p13.3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia.
    Acta Haematol. 2016;136:240-243.
    PubMed     Text format    
    
    
    September 2016
27. BALJEVIC M, Dumitriu B, Lee JW, Paietta EM, et al
    Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
    Acta Haematol. 2016;136:210-218.
    PubMed     Text format     Abstract available
    
    
    August 2016
28. HULEGARDH E, Punab M, Holmberg E, Palk K, et al
    Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years.
    Acta Haematol. 2016;136:167-173.
    PubMed     Text format     Abstract available
    
    
    
29. KAMODA Y, Izumi K, Iioka F, Akasaka T, et al
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution.
    Acta Haematol. 2016;136:157-166.
    PubMed     Text format     Abstract available
    
    
    May 2016
30. BYUN JM, Lee JO, Bang SM, Yu ES, et al
    8p11 Myeloproliferative Syndrome with t(7;8) Translocation Presenting as Acute Myeloid Leukemia: A Case Report and Literature Review.
    Acta Haematol. 2016;136:71-75.
    PubMed     Text format    
    
    
    April 2016
31. YAN W, Zhang G
    Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
    Acta Haematol. 2016;136:1-15.
    PubMed     Text format     Abstract available
    
    
    March 2016
32. LI X, Zhu H, Zhang Y, Zhao W, et al
    The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
    Acta Haematol. 2016;135:217-223.
    PubMed     Text format     Abstract available
    
    
    January 2016
33. SCHILLER GJ
    High-Intensity Induction in the Elderly.
    Acta Haematol. 2016;135:53-4.
    PubMed     Text format    
    
    
    
34. FARINA M, Rossi G, Bellotti D, Marchina E, et al
    Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia.
    Acta Haematol. 2016;135:39-42.
    PubMed     Text format     Abstract available
    
    
    
35. KAEDA J, Ringel F, Oberender C, Gresse M, et al
    Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2016;136:62-4.
    PubMed     Text format    
    
    
    
36. SANTOLERI F, Lasala R, Ranucci E, La Barba G, et al
    Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
    Acta Haematol. 2016;136:45-51.
    PubMed     Text format     Abstract available
    
    
    
37. AMITAI I, Leader A, Raanani P
    Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead.
    Acta Haematol. 2016;136:43-4.
    PubMed     Text format    
    
    
    
38. NORSWORTHY KJ, Bhatnagar B, Singh ZN, Gojo I, et al
    Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature.
    Acta Haematol. 2016;135:241-51.
    PubMed     Text format     Abstract available
    
    
    
39. ALSHIEKH-NASANY R, Douer D
    L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity.
    Acta Haematol. 2016;135:208-10.
    PubMed     Text format     Abstract available
    
    
    
40. SHANSHAL M, Shakespeare A, Thirumala S, Fenton B, et al
    Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature.
    Acta Haematol. 2016;136:219-228.
    PubMed     Text format     Abstract available
    
    
    
41. GONG D, Li W, Hu LD, Shen JL, et al
    Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
    Acta Haematol. 2016;136:201-209.
    PubMed     Text format     Abstract available
    
    
    
42. ZHANG G, Dong F, Luan C, Zhang X, et al
    Overexpression of CCAAT Enhancer-Binding Protein alpha Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway.
    Acta Haematol. 2016;136:65-70.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: